Yatharth Hospital & Trauma Care Services Ltd
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]
- Market Cap ₹ 5,297 Cr.
- Current Price ₹ 617
- High / Low ₹ 693 / 360
- Stock P/E 41.0
- Book Value ₹ 109
- Dividend Yield 0.00 %
- ROCE 23.9 %
- ROE 21.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 95.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.0%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 98.7 to 131 days.
- Working capital days have increased from 84.5 days to 123 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of Nifty Microcap 250 Nifty Total Market BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
71 | 78 | 91 | 136 | 215 | 375 | 478 | 635 | 774 | |
53 | 60 | 71 | 98 | 147 | 263 | 343 | 453 | 573 | |
Operating Profit | 18 | 18 | 20 | 38 | 68 | 112 | 135 | 182 | 201 |
OPM % | 25% | 24% | 22% | 28% | 32% | 30% | 28% | 29% | 26% |
0 | 0 | 0 | 0 | 1 | 2 | 3 | 16 | 18 | |
Interest | 6 | 5 | 7 | 20 | 20 | 23 | 23 | 11 | 5 |
Depreciation | 7 | 6 | 8 | 21 | 21 | 28 | 28 | 29 | 43 |
Profit before tax | 5 | 8 | 5 | -2 | 28 | 63 | 88 | 157 | 171 |
Tax % | 41% | 23% | 21% | -18% | 30% | 30% | 25% | 27% | |
3 | 6 | 4 | -2 | 20 | 44 | 66 | 114 | 129 | |
EPS in Rs | 2.21 | 3.75 | 2.43 | -0.79 | 11.09 | 6.74 | 10.04 | 13.33 | 15.06 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 47% |
3 Years: | 43% |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 96% |
3 Years: | 85% |
TTM: | 52% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 58% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 29% |
Last Year: | 22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 14 | 16 | 16 | 16 | 16 | 66 | 66 | 86 | 86 |
Reserves | 29 | 41 | 39 | 38 | 56 | 51 | 117 | 788 | 846 |
85 | 125 | 175 | 194 | 193 | 264 | 267 | 85 | 90 | |
10 | 11 | 26 | 39 | 43 | 45 | 36 | 60 | 71 | |
Total Liabilities | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,093 |
54 | 53 | 164 | 189 | 251 | 303 | 299 | 442 | 507 | |
CWIP | 64 | 110 | 65 | 62 | 0 | 0 | 0 | 0 | 2 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 30 | 27 | 36 | 58 | 123 | 187 | 577 | 584 | |
Total Assets | 138 | 193 | 257 | 287 | 309 | 426 | 486 | 1,019 | 1,093 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
25 | 17 | 17 | 39 | 44 | 60 | 64 | -3 | |
-50 | -51 | -78 | -43 | -21 | -52 | -20 | -226 | |
26 | 43 | 47 | 5 | -19 | -1 | -18 | 304 | |
Net Cash Flow | 1 | 9 | -13 | 1 | 3 | 7 | 26 | 75 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 58 | 44 | 48 | 45 | 62 | 83 | 82 | 131 |
Inventory Days | 47 | 42 | 88 | 72 | ||||
Days Payable | 127 | 106 | 490 | 347 | ||||
Cash Conversion Cycle | -22 | -20 | -354 | -229 | 62 | 83 | 82 | 131 |
Working Capital Days | 44 | 29 | 7 | -11 | 23 | 52 | 79 | 123 |
ROCE % | 8% | 6% | 7% | 18% | 26% | 27% | 24% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28 Nov - Schedule of Analysts/Investors meeting on November 29, 2024.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26 Nov - Schedule of analysts/investors meeting on November 27, 2024.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
26 Nov - Corporate presentation for November 2024 submitted.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25 Nov - Schedule of analysts/investors meeting on November 26, 2024.
Concalls
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
Hospital Portfolio: [1]
- Total Hospitals: 7 hospitals across North India with 87% of the beds in Metro.
Locations and Beds:[2]
- Greater Noida: 400 beds (112 ICU beds, 66% occupancy).
- Noida: 250 beds (81 ICU beds, 83% occupancy).
- Noida Extension: 450 beds (125 ICU beds, 60% occupancy).
- Jhansi-Orchha: 305 beds (76 ICU beds, 47% occupancy).
- Greater Faridabad: 200 beds (61 ICU beds, ramping up at 28% occupancy).